Cited by 45RNA and protein synthesis mechanismsMitochondrial Function and PathologyRNA modifications and cancer

Pathogenic mechanism of a human mitochondrial tRNA Phe mutation associated with myoclonic epilepsy with ragged red fibers syndrome

Open access
Ling, Jiqiang, Roy, Hervé, Qin, Daoming, Rubio, Mary Anne T., Alfonzo, Juan D., Fredrick, Kurt, Ibba, Michael·2007·Proceedings of the National Academy of Sciences

Abstract

Human mitochondrial tRNA (hmt-tRNA) mutations are associated with a variety of diseases including mitochondrial myopathies, diabetes, encephalopathies, and deafness. Because the current understanding of the precise molecular mechanisms of these mutations is limited, there is no efficient method to treat their associated mitochondrial diseases. Here, we use a variety of known mutations in hmt-tRNA(Phe) to investigate the mechanisms that lead to malfunctions. We tested the impact of hmt-tRNA(Phe) mutations on aminoacylation, structure, and translation elongation-factor binding. The majority of the mutants were pleiotropic, exhibiting defects in aminoacylation, global structure, and elongation-factor binding. One notable exception was the G34A anticodon mutation of hmt-tRNA(Phe) (mitochondrial DNA mutation G611A), which is associated with MERRF (myoclonic epilepsy with ragged red fibers). In vitro, the G34A mutation decreases aminoacylation activity by 100-fold, but does not affect global folding or recognition by elongation factor. Furthermore, G34A hmt-tRNA(Phe) does not undergo adenosine-to-inosine (A-to-I) editing, ruling out miscoding as a possible mechanism for mitochondrial malfunction. To improve the aminoacylation state of the mutant tRNA, we modified the tRNA binding domain of the nucleus-encoded human mitochondrial phenylalanyl-tRNA synthetase, which aminoacylates hmt-tRNA(Phe) with cognate phenylalanine. This variant enzyme displayed significantly improved aminoacylation efficiency for the G34A mutant, suggesting a general strategy to treat certain classes of mitochondrial diseases by modification of the corresponding nuclear gene.

Integrity signals

Registry

Crossref · 10.1073/pnas.0704441104

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • m.611G N A decreases aminoacylation activity 100-fold in vitro.

    “Recent examples include the mt-tRNA Phe m.611G N A mutation, which decreases aminoacylation activity 100-fold in vitro [203]”

    From Mitochondrial DNA mutations and human disease (2010) · cites this paper as [203]

  • Aminoacylation efficiency of mutant mt-tRNA Phe with m.611G N A was significantly improved by modifying the mt-tRNA binding domain of cognate phenylalanyl-tRNA synthetase.

    “Aminoacylation efficiency of mutant mt-tRNA Phe , carrying the m.611G N A MERRF mutation, was significantly improved following modification of the mt-tRNA binding domain of the cognate phenylalanyl-tRNA synthetase [203].”

    From Mitochondrial DNA mutations and human disease (2010) · cites this paper as [203]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ling, J., Roy, H., Qin, D., Rubio, M. A. T., Alfonzo, J. D., Fredrick, K., & Ibba, M.
Affiliations
The Ohio State University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2007-09-25
Volume
104
Issue
39
Pages
15299-15304
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2040369986
Cited by
45
References
72
Citations by year
2026: 2 · 2025: 4 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2017: 3 · 2016: 1 · 2015: 5 · 2013: 1 · 2012: 3
FWCI
1.72
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Chapman University Digital Commons (Chapman University) (submittedVersion)
Funders
  • National Science Foundation (0344002, 0620707)
  • American Heart Association
  • United States-Israel Binational Science Foundation
  • National Institutes of Health (GM 072528)
  • National Institute of General Medical Sciences (GM072528, R01GM072528)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
Keywords
myoclonic epilepsy with ragged-red fibers, MERRF, aminoacylation, phenylalanyl-tRNA synthetase, tRNA structure, A-to-I RNA editing, mitochondrial disease, pleiotropic mutations
MeSH terms
RNA, Mitochondrial, Anticodon, Base Sequence, Epilepsies, Myoclonic, Humans, Kinetics, Mitochondria, Molecular Conformation, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Peptide Elongation Factor Tu, Phenylalanine, RNA, RNA, Transfer, Phe, MERRF Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review